New data show most patients now stay on Wegovy, Zepbound after a year
PIK Professor Ezekiel Emanuel says that increased insurance coverage might be turning the tide against low persistence on weight-loss drugs.
How much will you save or lose with Trump’s ‘big’ tax bill?
The Penn Wharton Budget Model has helped develop a financial calculator that shows what each American will pay if Republican tax cut legislation passes the House.
How to handle misinformation without starting a fight
Javier Granados Samayoa of the Annenberg Public Policy Center explains how “bypassing misinformation” helps avoid arguments while clearing up political falsehoods.
First author Qiuyue Nie (left) and coauthor Maria Zotova purify samples of the fungus.
(Image: Bella Ciervo)
Penn engineers turn toxic fungus into anti-cancer drug
Researchers turn a toxic fungus into cancer-fighting drug
A study by Xue (Sherry) Gao of the School of Engineering and Applied Science and colleagues found potent cancer-killing effects in the deadly Aspergillus flavus fungus, which was linked to rumors of a “pharaoh’s curse.”
How scientists made the first gene-editing treatment for a baby
Rebecca Ahrens-Nicklas and Kiran Musunuru of the Perelman School of Medicine and Children’s Hospital of Philadelphia explain the implications of their treatment of a child with a rare genetic disorder using personalized gene-editing.
Food assistance programs should incentivize healthier eating. Here’s why
Christina Roberto and Alyssa Moran of the Perelman School of Medicine write that subsidizing sugary drinks with SNAP rewards an industry that limits choices for lower-income families to ensure that lowest-quality food is the most available and affordable option.
Lauren Nelson Hyppolite is the managing director of Research, Centers, and Academic Initiatives at the Wharton School.
nocred